Armistice Capital’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$83.2M Buy
2025
Q1
$76.9M Buy
2024
Q4
$95.9M Buy
2024
Q3
$101M Buy
2024
Q2
$89.7M Buy
2024
Q1
$69.9M Buy
2023
Q4
$60.5M Buy
2023
Q3
$39.8M Buy